| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.07 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.39 | 6e-08 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.45 | 1e-13 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.51 | 0.06 |